ADC Therapeutics entered int USD 115 m credit facility for secured convertible loans with Deerfield: the advisor

On April 24, 2020, ADC Therapeutics – a late clinical-stage oncology-focused biotechnology company headquartered in the Lausanne area that went public on the New York Stock Exchange on May 15 – entered into a USD 115 m credit facility for senior secured convertible loans entered into with funds affiliated with Deerfield Management Company. On May 19, 2020, the initial disbursement of such convertible term loan in the amount of USD 65 m took place.

The team

Homburger advised ADC Therapeutics on this transaction. The team was led by partner Dieter Gericke (corporate and m&a – pictured) and included partners Benjamin Leisinger (banking and finance) and Stefan Oesterhelt (tax) as well as associates Daniel Häusermann, Anna Peter, Estelle Piccard (corporate and m&a), Alessandra Mengotti and Pierina Janett-Seiler (both banking and finance).
ADC Therapeutics entered int USD 115 m credit facility for secured convertible loans with Deerfield: the advisor

FabioAdmin

Legalcommunity.ch

Launched in 2020 by LC Publishing Group, it is the first digital portal addressed to the Swiss legal market.
In terms of contents, the website focuses on both law firms and in-house legal departments, covering the latest news and rumors on deals and operations (and the related advisors) as well as on lateral hires, moves and new appointments and providing insights, analytical data and opinions on the professions’ main trends and topics (Ai, innovation, etc.).

For further information, please visit the Group’s website www.lcpublishinggroup.com

LC Publishing Group S.p.A. – Via Tolstoi 10 – 20146 Milano – Tel. 0236727659 – C.F./P.IVA 07619210961
REA 1971432 Registro delle Imprese di Milano – Cap. Soc. Euro 50.000,00 i.v.

Copyright 2022 © All rights Reserved. Design by Origami Creative Studio

SHARE

Share on linkedin
Share on twitter
Share on facebook
Share on whatsapp
Share on email
Share on telegram